Your browser doesn't support javascript.
loading
The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells.
Pozniak, Marta; Porebska, Natalia; Krzyscik, Mateusz Adam; Sokolowska-Wedzina, Aleksandra; Jastrzebski, Kamil; Sochacka, Martyna; Szymczyk, Jakub; Zakrzewska, Malgorzata; Otlewski, Jacek; Opalinski, Lukasz.
Afiliação
  • Pozniak M; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Porebska N; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Krzyscik MA; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Sokolowska-Wedzina A; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Jastrzebski K; Laboratory of Cell Biology, International Institute of Molecular and Cell Biology, Warsaw, Poland.
  • Sochacka M; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Szymczyk J; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Zakrzewska M; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Otlewski J; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland.
  • Opalinski L; Faculty of Biotechnology, Department of Protein Engineering, University of Wroclaw, Joliot-Curie 14a, 50-383, Wroclaw, Poland. lukasz.opalinski@uwr.edu.pl.
Mol Med ; 27(1): 46, 2021 05 07.
Article em En | MEDLINE | ID: mdl-33962559

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Med Ano de publicação: 2021 Tipo de documento: Article